Stephan Jenn's Biography

Stephan Jenn, President, Novalix

Stephan Jenn is the founder and President of the NovAliX Group, a group of companies that provides research capabilities in the field of chemistry, biophysics and integrated drug discovery. Before co-founding Novalyst Discovery, the first company of the NovAliX Group in 2002, Stephan Jenn was Vice President of Corporate Development at Graffinity Pharmaceuticals AG (now Santhera Pharmaceuticals, Liestal, Switzerland). Previously Mr. Jenn worked in international corporate finance as Engagement Director for Mazars in Paris then in Frankfurt. Stephan Jenn is a graduate from Rouen Graduate School of Management and received his MBA from University of Pennsylvania's Wharton Business School.